OHSU Doernbecher is first hospital in Pacific Northwest to offer new FDA-approved treatment for advanced leukemia Kymriah, first gene transfer therapy in the U.S., now available for children and young adults with ALL
Eneida Nemecek, M.D., M.S., M.B.A., (third from right) and the OHSU Doernbecher CAR-T cell therapy team. (OHSU)
KCCP Board Meeting
